ORCHARD- Optimising Home Assessment of Rural Patients

Inclusion criteria

• ● Solid organ transplant recipient

• On the COVID-19 shielding list
• People with specific cancers

• People with cancer who had chemotherapy within the last 2 years
• People with lung cancer that have had radical radiotherapy within the last two years
• People with cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at end stage treatment
• People that have had immunotherapy or other continuing antibody treatments for cancer within the last two years
• People that had other targeted cancer treatment which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors within the last two years
• People who had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
• People with severe respiratory conditions including all cystic fibrosis, severe asthma, and severe COPD
• People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell anaemia)
• People in immunosuppression therapies sufficient to significantly increase risk of infection

Inclusion criteria

for GPs:

• A GP working at the pilot study practice and carried out telemedicine consultations with participants
• A GP who can provide informed consent

Exclusion criteria

• People whose GP feels they are not able to participate in the research. People unable to consent to participate. Non-English speakers

Exclusion criteria

for GPs:

A GP that cannot provide informed consent